Xanthohumol Supplementation Modulates Microbiota-Derived Bile Acids, Potentially Ameliorating Crohn's Disease Symptoms.
Modulation of Microbiota-Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation.
Abstract
Xanthohumol, a hop flavonoid, was investigated in a randomized trial to modulate gut microbiota-derived bile acids and ameliorate Crohn's disease symptoms.